Jefferies Group LLC Merck & Co., Inc. Put Options Transaction History

Jefferies Group LLC

$10.2 Billion
Q3 2022

Put Options

28 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2022 Sep 21, 2023	SELL	$84.53 - $94.96 $1.06 Million - $1.19 Million	-12,500 Reduced 12.82%	85,000 $7.32 Million
Q3 2022 Nov 14, 2022	SELL	$84.53 - $94.96 $1.06 Million - $1.19 Million	-12,500 Reduced 12.82%	85,000 $7.32 Million
Q2 2022 Sep 21, 2023	SELL	$83.49 - $94.64 $18.2 Million - $20.6 Million	-218,000 Reduced 69.1%	97,500 $8.89 Million
Q2 2022 Aug 15, 2022	SELL	$83.49 - $94.64 $18.2 Million - $20.6 Million	-218,000 Reduced 69.1%	97,500 $8.89 Million
Q1 2022 Sep 21, 2023	BUY	$73.51 - $82.4 $7.23 Million - $8.11 Million	98,400 Added 45.32%	315,500 $25.9 Million
Q1 2022 May 16, 2022	BUY	$73.51 - $82.4 $7.23 Million - $8.11 Million	98,400 Added 45.32%	315,500 $25.9 Million
Q4 2021 Sep 21, 2023	SELL	$72.28 - $90.54 $72,280 - $90,540	-1,000 Reduced 0.46%	217,100 $16.6 Million
Q4 2021 Feb 14, 2022	SELL	$72.28 - $90.54 $72,280 - $90,540	-1,000 Reduced 0.46%	217,100 $16.6 Million
Q3 2021 Sep 21, 2023	BUY	$71.68 - $78.83 $15.5 Million - $17 Million	216,100 Added 10805.0%	218,100 $16.4 Million
Q3 2021 Nov 15, 2021	BUY	$71.68 - $78.83 $15.5 Million - $17 Million	216,100 Added 10805.0%	218,100 $16.4 Million
Q2 2021 Aug 20, 2021	SELL	$70.31 - $77.77 $13.9 Million - $15.4 Million	-198,000 Reduced 99.0%	2,000 $156,000
Q2 2021 Aug 16, 2021	BUY	$70.31 - $77.77 $13.9 Million - $15.4 Million	198,000 Added 9900.0%	200,000 $156,000
Q1 2021 Sep 21, 2023	SELL	$68.86 - $81.11 $241,010 - $283,885	-3,500 Reduced 63.64%	2,000 $147,000
Q1 2021 May 14, 2021	SELL	$68.86 - $81.11 $241,010 - $283,885	-3,500 Reduced 63.64%	2,000 $154,000
Q4 2020 Sep 21, 2023	SELL	$71.77 - $79.65 $5.71 Million - $6.33 Million	-79,500 Reduced 93.53%	5,500 $429,000
Q3 2020 Nov 13, 2020	SELL	$73.18 - $82.95 $1.36 Million - $1.54 Million	-18,600 Reduced 77.18%	5,500 $456,000
Q2 2020 Aug 14, 2020	SELL	$70.42 - $80.13 $5.9 Million - $6.71 Million	-83,800 Reduced 77.66%	24,100 $1.86 Million
Q1 2020 May 15, 2020	SELL	$63.36 - $87.82 $3.71 Million - $5.15 Million	-58,600 Reduced 35.2%	107,900 $8.3 Million
Q4 2019 Feb 13, 2020	SELL	$77.58 - $87.54 $11.1 Million - $12.5 Million	-142,900 Reduced 46.19%	166,500 $15.1 Million
Q3 2019 Nov 13, 2019	SELL	$76.08 - $82.93 $16.3 Million - $17.8 Million	-214,600 Reduced 40.95%	309,400 $26 Million
Q2 2019 Aug 14, 2019	BUY	$69.84 - $81.59 $15.4 Million - $17.9 Million	219,800 Added 72.26%	524,000 $43.9 Million
Q1 2019 May 15, 2019	SELL	$69.58 - $79.36 $9.77 Million - $11.1 Million	-140,400 Reduced 31.58%	304,200 $25.3 Million
Q4 2018 Feb 14, 2019	BUY	$65.24 - $75.71 $3.19 Million - $3.7 Million	48,900 Added 12.36%	444,600 $34 Million
Q3 2018 Nov 14, 2018	BUY	$57.69 - $67.84 $14.3 Million - $16.8 Million	247,200 Added 166.46%	395,700 $28.1 Million
Q2 2018 Aug 14, 2018	SELL	$50.83 - $59.72 $5.56 Million - $6.53 Million	-109,300 Reduced 42.4%	148,500 $9.01 Million
Q1 2018 May 15, 2018	SELL	$50.96 - $59.23 $13.1 Million - $15.3 Million	-257,600 Reduced 49.98%	257,800 $14 Million
Q4 2017 Feb 14, 2018	BUY	$51.62 - $61.64 $23.1 Million - $27.6 Million	447,700 Added 661.3%	515,400 $29 Million
Q3 2017 Nov 14, 2017	BUY	$58.67 - $63.13 $3.97 Million - $4.27 Million	67,700	67,700 $4.34 Million

Others Institutions Holding MRK

# of Institutions

3,821

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

Vanguard Group Inc Valley Forge, PA

250M
Shares

$24.1 Billion
0.52% of portfolio
Black Rock Inc. New York, NY

207M
Shares

$20 Billion
0.59% of portfolio
State Street Corp Boston, MA

119M
Shares

$11.5 Billion
0.56% of portfolio
Wellington Management Group LLP Boston, MA

75.8M
Shares

$7.3 Billion
1.55% of portfolio
Geode Capital Management, LLC Boston, MA

59.2M
Shares

$5.7 Billion
0.55% of portfolio

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $244B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.

Account